2011 Scientific Meeting of the National Antimicrobial Resistance Monitoring System; Public Meeting; Request for Comments, 37356 [2011-15982]

Download as PDF 37356 Federal Register / Vol. 76, No. 123 / Monday, June 27, 2011 / Notices within 30 days of publication. Written comments and recommendations for the proposed information collection should be sent directly to the following: Office of Management and Budget, Paperwork Reduction Project, Fax: 202– 395–7285, E-mail: OIRA_SUBMISSION@OMB.EOP.GOV, Attn: Desk Officer for the Administration for Children and Families. Robert Sargis. Reports Clearance Officer. [FR Doc. 2011–15958 Filed 6–24–11; 8:45 am] BILLING CODE 4184–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2011–N–0471] 2011 Scientific Meeting of the National Antimicrobial Resistance Monitoring System; Public Meeting; Request for Comments AGENCY: Food and Drug Administration, HHS. Notice of public meeting; request for comments. ACTION: The Food and Drug Administration (FDA) is announcing a public meeting entitled: ‘‘2011 Scientific Meeting of the National Antimicrobial Resistance Monitoring System.’’ The topic to be discussed is animal and retail sampling methods for the National Antimicrobial Resistance Monitoring System (NARMS). Date and Time: The public meeting will be held on July 20, 2011, from 8 a.m. to 5 p.m. Location: The public meeting will be held at Holiday Inn Select St. Louis Downtown Convention Center Hotel, 811 North 9th Street, St. Louis, MO 63101, 314–421–4000, FAX: 314–421– 5974. Contact Person: Aleta Sindelar, Center for Veterinary Medicine (HFV–3), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240–276– 9004, FAX: 240–276–9001, e-mail: Aleta.Sindelar@fda.hhs.gov. The main purpose of the meeting is to explore ways in which NARMS can improve sampling using current resources. Other topics include: (1) How should NARMS define adequate sampling for resistance trends? (2) What are some additional sources for unbiased food animal samples? (3) What additional information should NARMS collect and report? mstockstill on DSK4VPTVN1PROD with NOTICES SUPPLEMENTARY INFORMATION: VerDate Mar<15>2010 16:51 Jun 24, 2011 Jkt 223001 Requests for Oral Presentations: Interested persons may present data, information, or views, orally or in writing, on the topic of the discussion of the meeting. Written submissions may be made to the contact person on or before July 6, 2011. Oral presentations from the public during the open public comment period will be scheduled between approximately 2 and 3 p.m. on July 20, 2011. Those desiring to make oral presentations should notify the contact person by July 6, 2011, and submit a brief statement of the general nature of information they wish to present and an indication of the approximate time requested to make their presentation. Time allotted for each presentation may be limited. The contact person will inform each speaker of their schedule prior to the meeting. Registration is not required for this meeting, however, early arrival is recommended because seating may be limited. If you need special accommodations due to a disability, please contact Aleta Sindelar (see Contact Person) at least 7 days in advance. Comments: Regardless of attendance at the public meeting, interested persons may submit to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852, either electronic or written comments regarding this document. Submit electronic comments to https:// www.regulations.gov. It is only necessary to send one set of comments. It is no longer necessary to send two copies of mailed comments. Identify comments with the docket number found in brackets in the heading of this document. Received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. The docket will remain open for written or electronic comments for 30 days following the meeting. Agenda: The meeting will address goals and challenges of surveying retail meats and food animals for antimicrobial susceptibility in foodborne bacteria. The agenda for the public meeting will be made available on the Agency’s Web site at https:// www.fda.gov/AnimalVeterinary/ SafetyHealth/AntimicrobialResistance/ NationalAntimicrobial ResistanceMonitoringSystem/ ucm059135.htm. Transcripts: FDA will prepare a meeting transcript and make it available on the Agency’s Web site (see Agenda) after the meeting. FDA anticipates that transcripts will be available approximately 60 business days after PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 the meeting. The transcript will be available for public examination at the Division of Dockets Management (HFA– 305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852, between 9 a.m. and 4 p.m., Monday through Friday. A transcript will also be available in either hardcopy or on CD–ROM after submission of a Freedom of Information request. Written requests are to be sent to Division of Freedom of Information (ELEM–1029), Food and Drug Administration, 12420 Parklawn Dr., Element Bldg. Rockville, MD 20857. Dated: June 16, 2011. Leslie Kux, Acting Assistant Commissioner for Policy. [FR Doc. 2011–15982 Filed 6–24–11; 8:45 am] BILLING CODE 4160–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Submission for OMB review; comment request Health Information National Trends Survey 4 (HINTS 4) (NCI) Summary: Under the provisions of Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Cancer Institute (NCI), the National Institutes of Health (NIH), has submitted to the Office of Management and Budget (OMB) a request to review and approve the information collection listed below. This proposed information collection was previously published in the Federal Register on April 22, 2011 (76 FR 22714) and allowed 60-days for public comment. One public comment was received on April 23, 2011 which commented on the number of previous surveys and expense. An e-mail response was sent on April 25, 2011, stating, ‘‘Thank you for your comments. We will take your comments into consideration.’’ The purpose of this notice is to allow an additional 30 days for public comment. The National Institutes of Health may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. Proposed Collection: Title: Health Information National Trends Survey 4 (HINTS 4) (NCI) (OMB 0925–0538, Exp 11/30/2008). Type of Information Collection Request: Reinstatement with Change. Need and Use of Information Collection: HINTS 4 will provide NCI with a comprehensive assessment of the American public’s current access to, and E:\FR\FM\27JNN1.SGM 27JNN1

Agencies

[Federal Register Volume 76, Number 123 (Monday, June 27, 2011)]
[Notices]
[Page 37356]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-15982]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2011-N-0471]


2011 Scientific Meeting of the National Antimicrobial Resistance 
Monitoring System; Public Meeting; Request for Comments

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public meeting; request for comments.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing a public 
meeting entitled: ``2011 Scientific Meeting of the National 
Antimicrobial Resistance Monitoring System.'' The topic to be discussed 
is animal and retail sampling methods for the National Antimicrobial 
Resistance Monitoring System (NARMS).
    Date and Time: The public meeting will be held on July 20, 2011, 
from 8 a.m. to 5 p.m.
    Location: The public meeting will be held at Holiday Inn Select St. 
Louis Downtown Convention Center Hotel, 811 North 9th Street, St. 
Louis, MO 63101, 314-421-4000, FAX: 314-421-5974.
    Contact Person: Aleta Sindelar, Center for Veterinary Medicine 
(HFV-3), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 
20855, 240-276-9004, FAX: 240-276-9001, e-mail: 
Aleta.Sindelar@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: The main purpose of the meeting is to 
explore ways in which NARMS can improve sampling using current 
resources. Other topics include:
    (1) How should NARMS define adequate sampling for resistance 
trends?
    (2) What are some additional sources for unbiased food animal 
samples?
    (3) What additional information should NARMS collect and report?
    Requests for Oral Presentations: Interested persons may present 
data, information, or views, orally or in writing, on the topic of the 
discussion of the meeting. Written submissions may be made to the 
contact person on or before July 6, 2011. Oral presentations from the 
public during the open public comment period will be scheduled between 
approximately 2 and 3 p.m. on July 20, 2011. Those desiring to make 
oral presentations should notify the contact person by July 6, 2011, 
and submit a brief statement of the general nature of information they 
wish to present and an indication of the approximate time requested to 
make their presentation. Time allotted for each presentation may be 
limited. The contact person will inform each speaker of their schedule 
prior to the meeting.
    Registration is not required for this meeting, however, early 
arrival is recommended because seating may be limited.
    If you need special accommodations due to a disability, please 
contact Aleta Sindelar (see Contact Person) at least 7 days in advance.
    Comments: Regardless of attendance at the public meeting, 
interested persons may submit to the Division of Dockets Management 
(HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, 
Rockville, MD 20852, either electronic or written comments regarding 
this document. Submit electronic comments to https://www.regulations.gov. It is only necessary to send one set of comments. 
It is no longer necessary to send two copies of mailed comments. 
Identify comments with the docket number found in brackets in the 
heading of this document. Received comments may be seen in the Division 
of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. 
The docket will remain open for written or electronic comments for 30 
days following the meeting.
    Agenda: The meeting will address goals and challenges of surveying 
retail meats and food animals for antimicrobial susceptibility in 
foodborne bacteria. The agenda for the public meeting will be made 
available on the Agency's Web site at https://www.fda.gov/AnimalVeterinary/SafetyHealth/AntimicrobialResistance/NationalAntimicrobialResistanceMonitoringSystem/ucm059135.htm.
    Transcripts: FDA will prepare a meeting transcript and make it 
available on the Agency's Web site (see Agenda) after the meeting. FDA 
anticipates that transcripts will be available approximately 60 
business days after the meeting. The transcript will be available for 
public examination at the Division of Dockets Management (HFA-305), 
Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, 
MD 20852, between 9 a.m. and 4 p.m., Monday through Friday. A 
transcript will also be available in either hardcopy or on CD-ROM after 
submission of a Freedom of Information request. Written requests are to 
be sent to Division of Freedom of Information (ELEM-1029), Food and 
Drug Administration, 12420 Parklawn Dr., Element Bldg. Rockville, MD 
20857.

    Dated: June 16, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-15982 Filed 6-24-11; 8:45 am]
BILLING CODE 4160-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.